Five years after an NDMA-driven withdrawal, ranitidine has FDA approval again. A practical guide to all four H2 blockers, and where each still fits.
The hearing was similarly discussed by other legal commentators, with David Minsky of Law 360 reporting, ā€œZantac MDL Suits Were Improperly Tossed, 11th Circ. Toldā€ Cassandra Burke, one of my students ...
New York: Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports from several experts to support their claim that the heartburn ...
Law360 (February 18, 2025, 9:27 PM EST) -- Taking Zantac does not cause prostate cancer, a Children's Hospital Colorado toxicologist testified Tuesday in two men's Illinois retrial of claims that ...
Law360 (February 3, 2025, 8:31 PM EST) -- A Boehringer Ingelheim corporate representative testified Monday that the company considered changes to the color of its over-the-counter Zantac heartburn ...
Zantac was first approved by U.S. regulators in 1983 and quickly became the world's best-selling drug by 1988, surpassing $1 billion in annual sales. Over the years, it has been marketed by various ...
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...
GlaxoSmithKline (GSK), formerly known as Glaxo Wellcome and Beecham, has reached settlements regarding multiple lawsuits associated with its well-known heartburn medication, Zantac. The company ...
GlaxoSmithKline (GSK), voorheen bekend als Glaxo Wellcome and Beecham, heeft schikkingen getroffen in meerdere rechtszaken rondom het bekende maagzuurremmende medicijn Zantac. Het bedrijf heeft ...
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...